Glycotech Inc.
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Glycotech Inc.
GlycoMimetics’ Sickle Cell Candidate Nearly Ready For Hand-Over To Pfizer
Biotech focused on role of carbohydrates in biological processes completes Phase II program of lead candidate for sickle cell disease. Under a 2011 partnership, Pfizer takes over development of GMI-1070 in Phase III.
Company Information
- Industry
- Biotechnology
- Pharmaceuticals
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice